Innoviva Inc. Stock
Price
Target price
€16.40
€16.40
-
-
-
€30.00
22.08.24 / Stuttgart Stock Exchange
WKN: A2AC9U / Symbol: INVA / Name: Innoviva / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Innoviva Inc. Stock
Innoviva Inc. is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
As a result the target price of 30 € shows a very positive potential of 82.93% compared to the current price of 16.4 € for Innoviva Inc..
Pros and Cons of Innoviva Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Innoviva Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Innoviva Inc. | - | -0.606% | 0.613% | 37.815% | 14.685% | 27.132% | 67.313% |
| Gritstone Oncology Inc | 0.530% | -7.695% | -29.843% | -71.064% | -75.985% | -93.904% | - |
| Rockwell Medical Inc. | -7.540% | 12.945% | 44.605% | 24.700% | 49.942% | -50.050% | -88.377% |
| Pacira Pharmaceuticals | - | 6.957% | -32.787% | -64.244% | -58.725% | -74.795% | -61.925% |
Comments
Innoviva, Inc. (NASDAQ: INVA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for INVA provided by MarketBeat
Innoviva, Inc. (NASDAQ: INVA) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for INVA provided by MarketBeat
Innoviva, Inc. (NASDAQ: INVA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Show more
Ratings data for INVA provided by MarketBeat